These results demonstrate that the suppressive capabilities of SLE on melanoma cell survival, migration and invasion may be attributed to the inhibition of STAT3-targeted Mcl-1, Bcl-xL, MMP-2 and MMP-9. This evidence concerns the gene BCL2L1 and systemic lupus erythematosus.